UK to boost clinical trial participation

The UK government will take steps to make sure patients are better informed of opportunities to participate in clinical trials, according to the country's health minister. Doctors in the UK "already have a duty to advise patients, in each patient's best interest, about all aspects of their treatment, including research," a UK Department of Health spokesperson told __The Scientist__ in an Email. But UK Secretary of State for Health linkurl:Alan Johnson,;http://www.number-10.gov.uk/output/Page630

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The UK government will take steps to make sure patients are better informed of opportunities to participate in clinical trials, according to the country's health minister. Doctors in the UK "already have a duty to advise patients, in each patient's best interest, about all aspects of their treatment, including research," a UK Department of Health spokesperson told __The Scientist__ in an Email. But UK Secretary of State for Health linkurl:Alan Johnson,;http://www.number-10.gov.uk/output/Page6309.asp said that the duty will be clearly laid out in a soon-to-be-released constitution for the country's health service. In a speech he gave yesterday (Jun 24), commemorating the 60th anniversary of the United Kingdom's National Health Service (NHS), Johnson outlined plans to make sure patients are told of studies relevant to them and to and make sure information is shared between pharmaceutical companies, academic institutions and other research centers. "I want every patient in the NHS to have the right to take part in approved medical research that is appropriate for them, if they choose to," Johnson said at the summit, linkurl:according;http://nds.coi.gov.uk/Content/Detail.asp?ReleaseID=371664&NewsAreaID=2 to the UK Department of Health. "And to underline the paramount importance of research, we will set out in the forthcoming NHS constitution the core role that it plays at the heart of the NHS." The NHS constitution will be unveiled this Monday (Jun 30) in the House of Commons, where Parliament will review the document before it's publically released, according to the Email. The Department of Health spokesperson also wrote that the guideline to better inform British patients of clinical trials "will not be a formal rule" in the constitution. "We shall make it easier to use care records confidentially where necessary so that the NHS can identify patients who are suitable for a particular approved study; and then discuss it with them so that they can choose whether to take part." Concurrent with Johnson's speech, the NHS released a linkurl:report;http://www.nihr.ac.uk/files/pdfs/60%20years%20of%20research%20in%20the%20NHS%20benefiting%20patients%20final.pdf yesterday outlining the agency's pledge to enliven clinical trial participation. The report cites an almost $7 billion (USD) yearly pharmaceutical industry contribution to research and development in the UK - 40 percent of which goes towards clinical trials - and underscores the importance of collaboration between universities, government agencies, and pharma and biotech companies. It mentions the linkurl:UK Centre for Medical Research and Innovation;http://www.the-scientist.com/blog/display/53962/ as a prime example of such a partnership.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of small blue creatures called Nergals. Some have hearts above their heads, which signify friendship. There is one Nergal who is sneezing and losing health, which is denoted by minus one signs floating around it.
June 2025, Issue 1

Nergal Networks: Where Friendship Meets Infection

A citizen science game explores how social choices and networks can influence how an illness moves through a population.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

The Scientist Placeholder Image

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity 

The Scientist Placeholder Image

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

agilent-logo

Agilent Announces the Enhanced 8850 Gas Chromatograph

parse-biosciences-logo

Pioneering Cancer Plasticity Atlas will help Predict Response to Cancer Therapies